|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-319-18365-7 |
003 |
DE-He213 |
005 |
20220116050710.0 |
007 |
cr nn 008mamaa |
008 |
150619s2015 sz | s |||| 0|eng d |
020 |
|
|
|a 9783319183657
|9 978-3-319-18365-7
|
024 |
7 |
|
|a 10.1007/978-3-319-18365-7
|2 doi
|
050 |
|
4 |
|a QP356.3
|
072 |
|
7 |
|a PSAN
|2 bicssc
|
072 |
|
7 |
|a MED057000
|2 bisacsh
|
072 |
|
7 |
|a PSAN
|2 thema
|
082 |
0 |
4 |
|a 612.8042
|2 23
|
245 |
1 |
0 |
|a Natural Compounds as Therapeutic Agents for Amyloidogenic Diseases
|h [electronic resource] /
|c edited by Neville Vassallo.
|
250 |
|
|
|a 1st ed. 2015.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a VII, 163 p. 41 illus., 26 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|x 2214-8019 ;
|v 863
|
505 |
0 |
|
|a Olive Oil Phenols as Promising Multi-targeting Agents against Alzheimer's disease -- Alzheimer's disease, Drosophila melanogaster and Polyphenols -- Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's disease -- Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.- Brain Food for Alzheimer-free Ageing: Focus on Herbal Medicines -- Tea Polyphenols in Parkinson's disease -- The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism.
|
520 |
|
|
|a This edited volume concerns a group of devastating neurological disorders that share a common pathological mechanism, namely the aggregation and deposition of insoluble, proteinaceous lesions, termed 'amyloid'. Examples of cerebral amyloid disorders include common neurodegenerative diseases like Alzheimer's disease-related dementia and Parkinson's disease, as well as other less prevalent conditions like Huntington's disease, cerebral amyloid angiopathy and the transmissible prion disorders. A disease-modifying therapeutic agent is still lacking for all these diseases, and there are no approved therapies that target amyloid formation directly. Nevertheless, a large and complex group of natural aromatic compounds known as polyphenols are rapidly emerging as potentially potent anti-amyloidogenic agents. This book collectively presents a considerable body of experimental and epidemiological evidence from peer-reviewed scientific publications that support a role for natural compounds and herbal extracts in the chemoprevention and therapy of amyloidogenic disorders. Each contribution is written by scientific experts in the relevant field; chapters are devoted to Mediterranean diet and olive oil phenols, traditional Chinese medicine, herbal extracts, polyphenols (with a particular emphasis on epigallocatechin-3-gallate) and bi-flavonoids, amongst others. The topic of this book is relevant to a wide audience, from academia and university students in the biological and chemical sciences, to physicians and allied health professionals, as well as people working in the nutraceutical industry.
|
650 |
|
0 |
|a Neurochemistry.
|
650 |
|
0 |
|a Nutrition .
|
650 |
|
0 |
|a Neurology .
|
650 |
|
0 |
|a Pharmacy.
|
650 |
1 |
4 |
|a Neurochemistry.
|
650 |
2 |
4 |
|a Nutrition.
|
650 |
2 |
4 |
|a Neurology.
|
650 |
2 |
4 |
|a Pharmacy.
|
700 |
1 |
|
|a Vassallo, Neville.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319183664
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319183640
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319359502
|
830 |
|
0 |
|a Advances in Experimental Medicine and Biology,
|x 2214-8019 ;
|v 863
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-319-18365-7
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|